New vaccine trial aims to stop deadly rift valley fever
NCT ID NCT06799234
First seen Nov 17, 2025 · Last updated Jun 18, 2026 · Updated 29 times
Summary
This study tests a new vaccine called ChAdOx1 RVF to see if it can protect against Rift Valley Fever, a serious disease spread by mosquitoes. About 240 healthy adults in Kenya will receive either the new vaccine or a rabies vaccine for comparison. Researchers will check for side effects and measure immune responses over 18 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RIFT VALLEY FEVER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
KEMRI-Wellcome Trust Research Programme
Kilifi, Coast, 254, Kenya
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.